Lodo Therapeutics

Developing therapies to treat cancer and diabetes in partnership with Genentech/Roche.


The Partnership Fund and the state’s Innovate NY program invested in Lodo as part of its efforts to grow life sciences in New York. Lodo was spun out of the lab of Dr. Sean Brady at Rockefeller University by Accelerator Life Science Partners.


A drug discovery and development company focused on the creation of novel therapeutics derived from nature that will impact patients around the world.

Visit site